Innovations in otorhinolaryngology in the age of COVID‐19: A systematic literature review
E. McCarty+3 more
semanticscholar +1 more source
Otorhinolaryngology without borders
Agrício Nubiato Crespo+1 more
openaire +3 more sources
Partial Laryngectomy for Thyroid Cancer: A Single Institution Case Series With Operative Techniques
ABSTRACT Background Partial laryngectomy has been well described as a management option for T1–3 laryngeal squamous cell cancers. However, there are a few case reports of partial laryngeal surgery for locally advanced thyroid carcinoma. Methods This is a case series of five patients with thyroid carcinoma (one primary and four recurrent) with laryngeal
Ella E. Hawes+17 more
wiley +1 more source
Correction to: Oral health‑related quality of life among long‑term head and neck cancer survivors: a multinational study. [PDF]
Westgaard KL+14 more
europepmc +1 more source
Predictive Factors of Malignancy in Cervical Paragangliomas: A Retrospective Study
ABSTRACT Background Early predictive factors of metastatic cervical paragangliomas (cPG) are lacking. Methods This multicenter retrospective study included patients with at least one cPG. Metastatic cPG were defined by the histological presence of lymph node metastases or distant metastases.
Garance Haw+13 more
wiley +1 more source
Corrigendum to "SKP2 contributes to AKT activation by ubiquitination degradation of PHLPP1, impedes autophagy, and facilitates the survival of thyroid carcinoma" [Molecules and Cells Volume 46, Issue 6, June 2023, 360-373]. [PDF]
Shao Y+11 more
europepmc +1 more source
Patients with Dizziness Requiring Psychology Analysis in Otorhinolaryngology
Keiji Matsuzaki+2 more
openalex +2 more sources
ABSTRACT Background Head and neck cancer treatments can cause head and neck lymphoedema (HNL), impacting quality of life (QoL). This study examined lymphatic drainage changes in HNL using Indocyanine Green Lymphography (ICG‐L) and assessed QoL, physical, and functional outcomes.
Katrina Gaitatzis+7 more
wiley +1 more source
An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: the DUBHE randomized clinical trial. [PDF]
Xian M+33 more
europepmc +1 more source